Results 41 to 50 of about 2,872,478 (184)

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage [PDF]

open access: yes, 2015
Introduction: The presence of a new autoantibody system, anti-carbamylated protein (anti-CarP) antibodies, has been identified in rheumatoid arthritis (RA).
Klareskog, Lars   +39 more
core   +1 more source

Anti-carbamylated protein and peptide antibodies as potential inflammatory joint biomarkers in the relatives of rheumatoid arthritis patients [PDF]

open access: yes, 2020
Q4Q3Pacientes con Artritis reumatoideObjective: Antibodies against carbamylated proteins/peptide (CarP) have been associated with severity in rheumatoid arthritis (RA) patients.
Bautista-Molano, Wilson Armando   +17 more
core   +1 more source

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

open access: yesBMC Musculoskeletal Disorders, 2021
Background Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50–60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients for anti-TNF therapy.
Antonio Julià   +19 more
doaj   +1 more source

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis

open access: yesBMC Musculoskeletal Disorders, 2022
Objective Rheumatoid arthritis (RA) is often complicated with chronic lung diseases (CLD), including interstitial lung disease (ILD) and airway disease, which occur as extra-articular manifestations.
Shomi Oka   +13 more
doaj   +1 more source

Evaluation of anti-carbamylated protein antibodies as a potential biomarker in assisting the diagnosis of rheumatoid arthritis and its correlation with disease activity [PDF]

open access: yes, 2018
Rheumatoid arthritis (RA) is an inflammatory rheumatic disease characterized by the presence of autoantibodies. This study aims to determine the sensitivity and specificity of anti-carbamylated protein (anti-CarP) antibodies in rheumatoid arthritis ...
Othman, Maizatul Akmal
core   +1 more source

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis [PDF]

open access: yesMinia Journal of Medical Research, 2020
Objective: To investigate whether serum levels of anti-Carbamylated antibodies are specifically elevated in active rheumatoid arthritis compared to clinical and laboratory markers of disease activity.Methods: Sixty rheumatoid arthritis patients according
Ayman Darwesh   +2 more
doaj   +3 more sources

Evaluating the Diagnostic Accuracy of Rheumatoid Factor, Anti-citrullinated Protein Antibody and Anti-carbamylated Protein Antibody in Early Detection of Rheumatoid Arthritis: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Rheumatoid Arthritis (RA) is a systemic autoimmune disease that primarily affects synovial joints. Joint infiltration with immune cells is a characteristic feature of RA.
Karthiga Dhakshna Murthi   +3 more
doaj   +1 more source

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

open access: yesRMD Open, 2022
Background Predicting progression to clinical arthritis in individuals at-risk of developing rheumatoid arthritis is a prerequisite to developing stratification groups for prevention strategies. Selecting accurate predictive criteria is the critical step
Paul Emery   +7 more
doaj   +1 more source

A novel soluble immune-type receptor (SITR) in teleost fish: carp SITR is involved in the nitric oxide-mediated response to a protozoan parasite [PDF]

open access: yes, 2011
Background- The innate immune system relies upon a wide range of germ-line encoded receptors including a large number of immunoglobulin superfamily (IgSF) receptors.
Wiegertjes Geert F.   +28 more
core   +2 more sources

Effects of Dietary Mannan Oligosaccharides on Growth, Disease Resistance, and Gut Microbiota in Zebrafish

open access: yesAnimal Research and One Health, EarlyView.
Supplementation with mannan oligosaccharides (MOS) enhances growth, disease resistance, antioxidant capacity, and gut microbiota diversity while suppressing inflammation, apoptosis, and strengthening intestinal barrier integrity in zebrafish challenged with LPS or DSS.
Zhiyuan Lu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy